Thermal ablation to relieve pain from metastatic bone disease: a systematic review.
Nicolò GennaroLuca Maria SconfienzaFederico AmbrogiSara BoveriEzio LanzaPublished in: Skeletal radiology (2019)
All techniques achieved pain relief after 1 and 3 months, in up to 91% and 95% of patients respectively. MWA showed a negligible complication rate, whereas MRgFUS is associated with a noteworthy rate of adverse events. Future studies should adopt a standardized pain reporting scale to allow for meta-analysis.
Keyphrases
- chronic pain
- pain management
- systematic review
- neuropathic pain
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- small cell lung cancer
- case control
- prognostic factors
- randomized controlled trial
- emergency department
- current status
- postoperative pain
- patient reported outcomes
- adverse drug
- atrial fibrillation
- meta analyses
- catheter ablation
- electronic health record
- radiofrequency ablation
- bone loss